Annual Drug Patent Expirations for PEPCID+COMPLETE Pepcid Complete is a drug marketed by J And J Consumer Inc and is included in one NDA. It is available from four suppliers.…
The post New patent expiration for J And drug PEPCID COMPLETE appeared first…
New patent expiration for J And drug PEPCID COMPLETE Read Post »
Annual Drug Patent Expirations for PIFELTRO Pifeltro is a drug marketed by Msd Merck Co and is included in one NDA. It is available from one supplier. There is one…
The post New patent for Msd Merck drug PIFELTRO appeared first on DrugPatentWatch – Mak…
Annual Drug Patent Expirations for TAVALISSE Tavalisse is a drug marketed by Rigel Pharms Inc and is included in one NDA. There are fourteen patents protecting this drug. This drug…
The post New patent for Rigel Pharms drug TAVALISSE appeared first on …
Annual Drug Patent Expirations for PEPCID+AC Pepcid Ac is a drug marketed by J And J Consumer Inc and is included in three NDAs. It is available from two suppliers.…
The post New patent expiration for J And drug PEPCID AC appeared first on DrugPatentWa…
This chart shows the pharmaceutical companies with the most patents in Slovakia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pat…
Which pharmaceutical companies have the most drug patents in Slovakia? Read Post »
Roflumilast is the generic ingredient in two branded drugs marketed by Astrazeneca, Breckenridge, Hetero Labs Ltd Iii, Micro Labs, Mylan, Strides Pharma, and Torrent and, and is included in seven…
The post New tentative approval for Zydus Pharms drug r…
New tentative approval for Zydus Pharms drug roflumilast Read Post »
This chart shows the companies which have received the most New Combination exclusivities in the past five years. New Combinations are one of the categories for which the FDA grants…
The post Pharmaceutical companies with the most ‘New Combination’ dru…
Pharmaceutical companies with the most ‘New Combination’ drugs Read Post »
Annual Drug Patent Expirations for AMELUZ Ameluz is a drug marketed by Biofrontera and is included in one NDA. It is available from one supplier. The generic ingredient in AMELUZ…
The post New patent for Biofrontera drug AMELUZ appeared first on DrugPa…
Annual Drug Patent Expirations for DHIVY Dhivy is a drug marketed by Avion Pharms and is included in one NDA. The generic ingredient in DHIVY is carbidopa; levodopa. Additional details…
The post New patent for Avion Pharms drug DHIVY appeared first on …
Annual Drug Patent Expirations for EMERPHED Emerphed is a drug marketed by Nexus Pharms and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent for Nexus Pharms drug EMERPHED appeared first on DrugPatentW…
Get new actionable insights and updates from BiotechBlog
